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Received June 5, 2014; accepted October 15, 2014AbstractBackground: Management of diseases of the descending thoracic aorta is trending from open surgery toward thoracic endovascular aortic repair
(TEVAR), because TEVAR is reportedly associated with less perioperative mortality. However, comparisons between TEVAR and open surgery,
adjusting for patient comorbidities, have not been well studied. In this nationwide population-based study, we compared the outcomes between
TEVAR and open surgery in type B aortic dissection.
Methods: From 2003 to 2009, data on patients with type B aortic dissection who underwent either open surgery or TEVAR were obtained from
the National Health Insurance Research Database. Survival, length of stay, and complications were compared between TEVAR and open repair.
To minimize possible bias, we performed an additional analysis after matching patients by age, sex, and propensity score.
Results: A total of 1661 patients were identified, of whom 1542 underwent open repair and 119 TEVAR. Patients in the TEVAR group were older
(63.0 ± 15.4 years vs. 58.1 ± 13.1 years; p ¼ 0.001), included more males, and had more preoperative comorbidities. Thirty-day mortality in the
TEVAR group was significantly lower than that in the open repair group (4.2% vs. 17.8%; p < 0.001). The midterm survival rates in the unmatched
cohort between the open surgery and TEVAR groups at 1 year, 2 years, 3 years, and 4 years were 76%, 73%, 71%, and 68% vs. 92%, 86%, 82%, and
79%, respectively. The length of stay in the TEVAR group was shorter than that in the open repair group ( p ¼ 0.001). The TEVAR group had less
respiratory failure ( p ¼ 0.022) and fewer wound complications than the open repair group ( p ¼ 0.008). The matched cohort showed similar results.
Conclusion: TEVAR for type B aortic dissection repair has less perioperative mortality, a shorter length of hospitalization, a higher midterm
survival rate, less postoperative respiratory failure, and fewer wound complications than open surgery.
Copyright © 2015 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Management of diseases of the descending thoracic aorta
(DTA; e.g., aneurysm, dissection, and rupture) is trending
from open surgery toward thoracic endovascular repair
(TEVAR).1 In 2004, approximately 21% and 79% of patients
with DTA disease underwent TEVAR and open surgery,
respectively, compared with 55% and 45% in 2007.2 TEVAR
is reportedly associated with less perioperative mortality than
open surgery in the treatment of thoracic aortic aneurysm
(TAA): about 2.1e5% with TEVAR versus 6.7e12% with
open surgery.2,3
Aortic dissection is uncommon but fatal. Clouse et al4,5
reported that between 1980 and 1994, the overall incidence
of TAA was 10.4 per 100,000 person-years and that of acute
aortic dissection (AAD) was 3.5 per 100,000 person-years.
The overall 5-year survival rate is 56% for TAA and 32%
for AAD, and the perioperative mortality rate of aortic
dissection ranges from about 9% to 13%.6,7 The etiology,
patient demographics, and pathophysiology of aortic dissec-
tion differ between TAA and AAD, and patients with AAD
tend to be younger and have fewer comorbidities.4,8 Open
surgery repair was proved to improve the long-term survival of
patients with chronic aortic dissection.9 Although whether a
patient receives open or TEVAR repair may be dependent on
the patient's comorbidities, comparison of the survival rate and
complications after baseline comorbidity adjustment between
open repair and TEVAR for aortic dissection to avoid potential
bias has not been performed.
In this study, we conducted a population-based cohort
comparison of the long-term outcomes of elective open and
endovascular aortic repair for aortic dissection using data from
the Taiwan National Health Insurance Research Database,
which enrolled 99.6% of the inhabitants of Taiwan from 1995
to 2009.
2. Methods2.1. DatabaseData were obtained from the National Health Insurance
Research Database, which comprises deidentified secondary
data derived from the registration and claims data of the
Taiwan National Health Insurance program. As the single
payer of the medical insurance of Taiwan, the National Health
Insurance program began in 1995 and enrolled 99.6% of the
inhabitants of the country as of 2009. Each year, the Taiwan
National Health Research Institute collects and publishes the
registration and claims data released by the National Health
Insurance, cross-checked and validated on medical charts and
claims to ensure its accuracy. This study used the inpatient
claim datasets containing all inpatient claim and registration
data from 1996 to 2010. This study was exempted from review
by the Institutional Review Board of Taipei Veterans General
Hospital, Taipei, Taiwan because the datasets were deidenti-
fied, and informed consent was waived because of the anon-
ymous nature of the data.2.2. Study cohortWe identified the patients who had undergone open repair
(ICD-9-CM [International Classification of Diseases, 9th
version, Clinical Modification] procedure codes 38.35 and
38.45) or endovascular repair (ICD-9-CM procedure codes
39.73 and 39.79) with a diagnosis of thoracic aortic dissection
(ICD-9-CM disease code 441.01) from 2003 to 2009; the
admission date for the operation was designated as the index
date. We excluded patients with a follow-up period (look-back
period) of <2 years from enrollment into the National Health
Insurance plan and date of the operation. We also excluded
those who underwent any aortic operation (codes 35.93, 38.14,
38.34, 38.35, 38.44, 38.45, 38.64, 38.84, 39.22, 39.24, 39.25,
39.54, or 39.71) during the look-back period. Patients with
diagnostic codes for aortic dissection involving only unspec-
ified segments or only abdominal segments other than the
thoracic aorta (ICD-9-CM disease codes 441.00 and 441.02)
before or during the index hospitalization period were
excluded. Those who underwent concomitant open repair and
endovascular repair during the same hospitalization period
were also excluded. We used the strategy previously
described; patients with concomitant codes for cardiac pro-
cedures such as coronary artery bypass (36.1xe36.3x), valve
replacement (35.2x), aorta-to-great-vessel bypass (39.22 and
39.23), cardioplegia (39.63), and hypothermic arrest (39.62)
were excluded. This strategy eliminated patients with type A
dissections, and limited the study population to those with
DTA and thoracoabdominal aorta disease.2.3. ComorbiditiesBaseline comorbidities including previous myocardial
infarction (410.x), chronic renal failure (585.x), chronic
obstructive pulmonary disease (490.xe496.x), hypertension
(401.xe405.x), diabetes mellitus (250.x), stroke
(430.xe431.x, 433.x1, and 434.xx, excluding 434.x0 and
436.x), peripheral arterial occlusive disease (440.x, 441.2,
441.4, 441.7, 441.9, 443.1e443.9, 447.1, 557.1e557.9, and
V434), dyslipidemia (272.x), and valvular heart disease
(093.20e093.24, 394.0e397.1, 424.0e424.91, 746.3e746.6,
V42.2, and V43.3) were identified. Patients were divided into
groups according to a baseline Charlson comorbidity index of
0, 1e2, 3e4, or 5, as previously described.10,112.4. Identification of matched cohort for alternative
analysisWe matched each endovascular repair patient to an open
repair patient by propensity score matching. The propensity
score was constructed by age, sex, and all identified comor-
bidities mentioned, including previous myocardial infarction,
chronic renal failure, chronic obstructive pulmonary disease,
hypertension, diabetes mellitus, stroke, peripheral arterial
occlusive disease, dyslipidemia, valvular heart disease, and
Charlson comorbidity index. The matching process also
required that the age of each open repair patient be within 2
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and that they be of the same sex.2.5. OutcomesThe primary endpoint of this study was all-cause 30-day
mortality. The secondary endpoints were length of stay,
midterm mortality, and perioperative and late complications.
Each patient was followed up for a maximum of 4 years for
the midterm mortality analysis. Perioperative complications
were defined as complications occurring during the index
hospitalization period and included medical complications
(respiratory failure, pneumonia, urinary tract infection, acute
renal failure, stroke, and paraplegia) and surgical complica-
tions (tracheostomy, upper- and lower-limb vascular compli-
cations including thrombectomy or amputation, bowel
ischemia or resection, wound complications requiring surgical
treatment, and hemorrhage requiring surgical exploration).
Late complications were defined as complications occurring
after the index hospitalization period and included additional
aortic aneurysm repair procedures, bowel adhesions requiring
surgical treatment, bowel obstruction, and graft-related com-
plications including graft infection, enteric fistula, and inci-
sional hernia repair.2.6. Statistical analysisData management and computing were carried out using
Microsoft SQL Server 2012 (Microsoft Corporation, Red-
mond, WA, USA). Data analysis was performed using R sta-
tistics (Version 2.15.2; The R Foundation for Statistical
Computing, Vienna, Austria). Categorical variables were
compared using the c2 test or Fisher's exact test, as appro-
priate, and continuous variables were compared using Student
t test. Thirty-day and midterm survival were estimated using
KaplaneMeier analysis, and the statistical significance of
differences was determined using the log-rank test. Hazard
ratios (HRs) for survival according to the repair method were
analyzed using Cox proportional hazards regression analysis
after adjustment for patient characteristics and comorbidities
and hospital and surgeon characteristics. A p value <0.05 was
considered statistically significant.
3. Results3.1. Patient characteristicsA total of 1661 patients who underwent thoracic aortic
repair for aortic dissection were identified from the population
(Fig. 1). This unmatched cohort comprised 1542 patients who
underwent open repair and 119 patients who underwent
TEVAR (Table 1). Patients in the TEVAR group (63.0 ± 15.4
years of age) were older than those in the open repair group
(58.1 ± 13.1 years) ( p ¼ 0.001). In addition, the TEVAR
group contained more male patients, with a higher incidence
of previous myocardial infarcts, chronic pulmonary disease,
hypertension, peripheral arterial occlusive disease, anddyslipidemia, but a lower incidence of valvular heart disease.
The matched cohort consisted of 113 patients in the TEVAR
group and 113 patients in the open repair group; there was no
significant difference in age (62.5 ± 15.1 years vs. 62.6 ± 15.3
years, p ¼ 0.955) and proportion of male patients (83.2% vs.
83.2%, p ¼ 1.000) between the TEVAR and open repair
groups. Both groups had similar proportions of patients having
comorbidities from each category.3.2. MortalityIn the unmatched cohort, the 30-day mortality rates in the
TEVAR and open repair groups were 4.2% and 17.8%,
respectively. The 30-day mortality rate in the TEVAR group
was significantly lower than that in the open repair group
( p < 0.001) (Table 2). In the matched cohort, the 30-day
mortality rates in the TEVAR and open repair groups were
4.4% and 19.5%, respectively. Patients in the TEVAR group
had a significantly lower 30-day mortality rate than those in
the open repair group.
In the unmatched cohort, the midterm survival rates at 1
year, 2 years, 3 years, and 4 years were 76%, 73%, 71%, and
68%, respectively, in the open repair group and 92%, 86%,
82%, and 79%, respectively, in the TEVAR group (Fig. 2). In
the matched cohort, the survival rates at 1 year, 2 years, 3
years, and 4 years were 73%, 72%, 69%, and 67%, respec-
tively, in the open repair group and 92%, 85%, 83%, 81%, and
78%, respectively, in the TEVAR group (Fig. 3). The risk
analysis for mortality showed that TEVAR for aortic dissec-
tion had a lower risk of mortality than open repair (adjusted
HR ¼ 0.45, 95% confidence interval ¼ 0.27e0.73, p ¼ 0.001)
after adjustment for age, sex, previous myocardial infarction,
chronic renal failure, chronic obstructive pulmonary disease,
hypertension, diabetes mellitus, stroke, peripheral vascular
disease, dyslipidemia, and valvular heart disease. In the
matched cohort, the TEVAR group had a lower risk of mor-
tality than the open repair group (HR ¼ 0.51, 95% confidence
interval ¼ 0.28e0.94, p ¼ 0.032).3.3. Length of stayIn the unmatched cohort, the length of stay in the TEVAR
group was 19.8 ± 18.5 days (mean ± SD), which was
significantly shorter than that in the open repair group
(26.0 ± 25.3 days, p ¼ 0.001). In the matched cohort, the
length of stay in the TEVAR group was 20.3 ± 18.9 days,
which was also significantly shorter than that in the open
repair group (26.7 ± 19.7 days, p ¼ 0.021) (Fig. 4).3.4. ComplicationsComplications are listed in Table 3. In the unmatched
cohort, the most common complication was respiratory failure,
which was noted in 14.2% of patients in the open repair group
and in 6.7% of patients in the TEVAR group. The TEVAR
group had less respiratory failure ( p ¼ 0.022) and fewer
wound complications ( p ¼ 0.008). Although the patients in
Fig. 1. Study cohort selection flow chart. Of 6736 patients in the study cohort, 1441 underwent open repair and 117 underwent TEVAR. TEVAR ¼ thoracic
endovascular aortic repair.
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( p ¼ 0.063), higher rate of graft complication ( p ¼ 0.077),
and lower percentage of acute renal failure ( p ¼ 0.075), the
difference did not reach the preset significance level. Five
patients in the TEVAR group received reintervention for
additional aortic repair. Two received endovascular repair, twoTable 1
Patient characteristics.
Unmatched
Open repair (n ¼ 1542) TEVAR (
Patient
Mean age (SD) 58.1 (13.1) 63.0 (15.
Male sex (%) 1068 (69.3) 99 (83.
Previous myocardial infarct (%) 24 (1.6) 8 (6.7
Chronic renal failure (%) 19 (1.2) 3 (2.5
Chronic pulmonary disease (%) 89 (5.8) 13 (10.
Hypertension (%) 1096 (71.1) 97 (81.
Diabetes mellitus (%) 134 (8.7) 12 (10.
Old stroke (%) 106 (6.9) 8 (6.7
Peripheral arterial occlusive disease (%) 1 (8.4) 17 (14.
Dyslipidemia (%) 103 (6.7) 15 (12.
Valvular heart disease (%) 349 (22.6) 11 (9.2
Charlson index score level (%)
1e2 1190 (77.2) 84 (70.
3e4 220 (14.3) 18 (15.
5 132 (8.6) 17 (14.
SD ¼ standard deviation; TEVAR ¼ thoracic endovascular aortic repair.received open repair, and one received two additional repairs,
one endovascular and one open repair. Thirty-five patients in
the open repair group underwent 16 open repairs and 19
endovascular repairs. The TEVAR group had higher rates of
reintervention of open aortic repair (2.5%), additional endo-
vascular repair (2.5%), and additional repair with either openMatched
n ¼ 119) p Open repair (n ¼ 113) TEVAR (n ¼ 113) p
4) <0.001 62.5 (15.1) 62.6 (15.3) 0.955
2) 0.002 94 (83.2) 94 (83.2) >0.99
) <0.001 4 (3.5) 3 (2.7) >0.99
) 0.205 2 (1.8) 2 (1.8) >0.99
9) 0.024 11 (9.7) 11 (9.7) >0.99
5) 0.015 90 (79.6) 92 (81.4) 0.737
1) 0.605 17 (15.0) 12 (10.6) 0.320
) 0.950 9 (8.0) 7 (6.2) 0.604
3) 0.028 12 (10.6) 13 (11.5) 0.832
6) 0.015 11 (9.7) 14 (12.4) 0.525
) <0.001 8 (7.1) 10 (8.8) 0.623
0.095 0.382
6) 82 (72.6) 80 (70.8)
1) 22 (19.5) 18 (15.9)
3) 9 (8.0) 15 (13.3)
Table 2
Thirty-day mortality.
Unmatched Matched
Open repair (n ¼ 1542) TEVAR (n ¼ 119) p Open repair (n ¼ 113) TEVAR (n ¼ 113) p
30-d mortality <0.001 <0.001
Yes, n (%) 274 (17.8) 5 (4.2) 22 (19.5) 5 (4.4)
No, n (%) 1268 (82.2) 114 (95.8) 91 (80.5) 108 (95.6)
TEVAR ¼ thoracic endovascular aortic repair.
Fig. 2. Survival of unmatched cohort. KaplaneMeier curves showing midterm
survival of the TEVAR and open repair groups for type B aortic dissection in
the unmatched cohort. TEVAR ¼ thoracic endovascular aortic repair.
Fig. 3. Survival of matched cohort. KaplaneMeier curves showing midterm
survival of the TEVAR and open repair groups for type B aortic dissection in
the matched cohort. TEVAR ¼ thoracic endovascular aortic repair.
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higher in the TEVAR group than in the open repair group
(3.4% vs. 1.2%, p ¼ 0.077). In the matched cohort, the
TEVAR group had less respiratory failure ( p ¼ 0.004), less
acute renal failure ( p ¼ 0.049), and less wound complication
( p ¼ 0.029) (Fig. 5).
4. Discussion
This nationwide, population-based cohort study showed
that the 30-day mortality rate of patients with aortic dissection
who underwent TEVAR was significantly lower than that of
patients who underwent surgical repair in both the unmatched
(4.2% vs. 17.8%, p < 0.001) and the matched (4.4% vs.
19.5%, p < 0.001) groups. In addition, patients with aortic
dissection who underwent TEVAR showed significantly
shorter lengths of stay and better midterm survival rates.
The perioperative mortality rate after TEVAR is low.2,12
Conrad et al2 reported perioperative mortality rates of 9%
and 21% in patients with aortic dissection who underwent
TEVAR and open surgery, respectively. In our study, patients
who underwent TEVAR were older and had more comor-
bidities, including hypertension, previous myocardial in-
farcts, peripheral arterial occlusive disease, chronicFig. 4. Length of stay comparison. Bar chart comparing length of stay between
the open repair and TEVAR groups in both matched and unmatched cohorts.
The error bars indicate standard errors. TEVAR ¼ thoracic endovascular aortic
repair.
Table 3
Complications.
Unmatched Matched
Open repair (n ¼ 1542) TEVAR (n ¼ 119) p Open repair (n ¼ 113) TEVAR (n ¼ 113) p
Perioperative (%)
Respiratory failure 219 (14.2) 8 (6.7) 0.022 23 (20.4) 8 (7.1) 0.004
Urinary tract infection 57 (3.7) 2 (1.7) 0.435 3 (2.7) 2 (1.8) >0.99
Acute myocardial infarction 17 (1.1) 1 (0.8) >0.99 0 (0) 1 (0.9) >0.99
Acute renal failure 155 (10.1) 6 (5.0) 0.075 13 (11.5) 5 (4.4) 0.049
Paralysis 16 (1.0) 1 (0.8) >0.99 1 (0.9) 1 (0.9) >0.99
Stroke 4 (0.3) 2 (1.7) 0.063 1 (0.9) 2 (1.8) >0.99
Tracheostomy 79 (5.1) 4 (3.4) 0.395 9 (8.0) 4 (3.5) 0.153
Lower-limb vascular complication 23 (1.5) 3 (2.5) 0.427 2 (1.8) 3 (2.7) >0.99
Upper-limb vascular complication 4 (0.3) 1 (0.8) 0.311 1 (0.9) 1 (0.9) >0.99
Wound complication 69 (4.5) 0 (0) 0.008 6 (5.3) 0 (0) 0.029
Operation for hemorrhage 48 (3.1) 1 (0.8) 0.255 4 (3.5) 1 (0.9) 0.369
Late complication
Open aortic repair 16 (1.0) 3 (2.5) 0.150 1 (0.9) 3 (2.7) 0.622
Additional endovascular repair 19 (1.2) 3 (2.5) 0.205 0 (0) 2 (1.7) 0.498
Graft complication 19 (1.2) 4 (3.4) 0.077 1 (0.9) 4 (3.5) 0.369
Fistula 3 (0.2) 0 (0) >0.99 1 (0.9) 0 (0) >0.99
Incisional hernia 5 (0.3) 1 (0.8) 0.360 1 (0.9) 1 (0.9) >0.99
TEVAR ¼ thoracic endovascular aortic repair.
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derwent open surgery. However, the 30-day mortality rates in
the TEVAR and open surgery groups were 4.2% and 17.8%,
respectively. Compared with Conrad's study, mortality in our
study was lower. There were no baseline data on comorbid-
ities in the study by Conrad et al2; we speculated that this was
probably due to the inclusion of older patients in Conrad's
study (mean age 71.4 years vs. 58.1 years in our study). The
midterm results of TEVAR for descending aortic dissectionFig. 5. Complications. Bar chart showing complications of the open repair and TEVvaries in previous studies, with survival ranging from 59.1%
to 100% and a median follow-up of 2 years.12 The 1- and 5-
year survival rates were 86% and 65%, respectively, and
perioperative mortality was 4% in a study by Andersen
et al.13 Results of the study of Xu et al14 revealed that the 5-
year survival rate was 84% and perioperative mortality was
only 1.2%. Compared to open surgical repair, Conway et al15
reported that the 1-, 5-, and 7-year survival rates were 92%,
83%, and 70%, respectively, but the rate of perioperativeAR groups in unmatched cohort. TEVAR ¼ thoracic endovascular aortic repair.
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TEVAR group in our study showed comparable survival rates,
which were 92%, 86%, 82%, and 79% at 1 year, 2 years, 3
years, and 4 years, respectively (Appendix 1). In addition, the
shorter length of stay in the TEVAR group compared with the
surgical group in both the unmatched and the matched groups
was significant.
Common complications of DTA disease management
include spinal cord ischemia, respiratory failure, and renal
failure.16e18 In terms of such complications, TEVAR has
shown better outcomes than surgery, whereas TEVAR is
associated with higher rates of peripheral vascular compli-
cations and reintervention.3,19 Andersen et al13 stated that the
reintervention rate was 24%, whereas in our study it was
4.2%. The differences were assumed to be because the cases
who were treated for residual chronic DTA disease following
acute type A aortic dissection repair were included in the
study of Andersen et al.13 Nevertheless, our result regarding
additional repair is comparable with the 4.8% rate of sec-
ondary TEVAR or open repair for reintervention reported in
the study of Xu et al.14 In our study, the graft complication
rate was higher with TEVAR than with open surgery. The
wound complication rate was higher with open surgery than
with TEVAR. Czerny et al20 have stated that pronounced
remodeling of the descending aorta with extensive stent
coverage is warranted to achieve success. Although statistical
significance was not reached, higher rates of associated
complications such as stroke were seen with TEVAR than
with open surgery. The incidence of perioperative stroke that
most likely resulted from embolism during TEVAR was
about 1.2e4.6% in recent studies.16,21 In our study, the
perioperative stroke rate was 1.7%, which is comparable with
that in previous studies. Spinal cord ischemia in TEVAR is
correlated with the length of aorta covered and the number of
stents deployed, and occurs with an incidence of about
7.5%.22 In open surgery, however, the number of sacrificed
segmental arteries, sufficiency of the collateral supply, and
postoperative blood pressure maintenance are important for
the outcome, with immediate or delayed paraplegia occurring
in about 1.2e5.3% of patients and paraparesis in about
1.2e3%.15,23,24 In our study, there was no significant differ-
ence in the rate of paraplegia between the TEVAR and the
open surgery groups. While TEVAR without drainage was
shown to be associated with a high rate of spinal cord injury
(SCI) at 7.5%,22 proactive prevention, as utilized in actual
clinical practice, may lower the incidence of SCI.25 More-
over, the diagnosis of SCI may not be registered in admin-
istrative databases because the SCI may have been recovered
at discharge. The lack of significance in the statistical anal-
ysis was most likely due to the small total number of
observed complications, which made it difficult to detect
statistical significance. Our study showed higher rates of
wound complications ( p ¼ 0.029), respiratory failure
( p ¼ 0.004), and acute renal failure ( p ¼ 0.049) in the open
surgery group than in the TEVAR group. The possible
mechanisms of renal failure were that open surgery has to
have cross-clamping of the aorta and possible reimplantationof visceral arteries would affect the perfusion of the kidney,
predisposing to postoperative renal failure. Clamping and
declamping of the aorta after prolonged torso ischemia dur-
ing open repair may cause pulmonary failure.26 In terms of
late (>5-year) mortality and complications (e.g., reinterven-
tion, renal insufficiency, and stroke), previous studies have
shown that the late complication rates of TEVAR and open
surgery are similar.2,13,27 Hanna et al28 have reported long-
term outcomes of TEVAR for acute complicated type B
dissection with 0% 30-day mortality and 84% survival rate at
5 years and 7 years; however, more clinical trials are required
to address this similarity.
This study has several limitations. First, there is unfortu-
nately no code for ascending aortic dissection among the ICD-
9-CM codes; thus, aortic dissection involving the ascending
aorta could be included. However, the method that we used,
which incorporated procedure codes that excluded patients
with aortic dissection involving the ascending aorta, may have
minimized the selection bias. This is because it is very unusual
that ascending aorta repair is performed without concomitant
coronary artery bypass, valve replacement, aorta-to-great-
vessel bypass, cardioplegia, or hypothermic arrest, which we
used as criteria to identify our study cohort and which have
also been used in previous studies.2 Therefore, we believe that
the selection bias may be minimal. Nonetheless, this selection
bias was present in both the open repair and the TEVAR
groups; therefore, the relationship and comparison between
the two groups may still be valid. Second, the complications
may have been overestimated. The database we used in this
study was a secondary database, and we did not have original
charts to review; however, the validity of the database was
analyzed and published in a previous study.29 Third, compli-
cations were recorded based on the claims database, and the
complication rates may have been overestimated because it
could not be determined if the complications were directly
associated with aortic repair. The complications may also have
been underestimated because the claims database is limited to
five diagnostic codes in the reimbursement application. If
many complications occurred during the reimbursement
application period, some complications, especially minor
ones, may not have been recorded. However, because this
potential overestimation applied to both repair groups, the
comparison results between the two groups may still be valid.
Fourth, we acknowledge that baseline hemostatic status pa-
rameters such as the blood pressure and fluid status were not
available in this study. Moreover, patients with unstable vital
signs tend to favor endovascular repair, increasing the mor-
tality of TEVAR because of the bias of the baseline fluid status
and thus minimizing the differences in the observed results in
our study. However, our results still showed that the risks of
short- and midterm mortality with TEVAR were lower than
those with open repair.
In conclusion, TEVAR for type B aortic dissection showed
less perioperative mortality, higher survival rates, shorter
lengths of stay, higher midterm survival rates, and fewer
wound and graft complications than open repair in this
nationwide longitudinal cohort study.
Appendix 1. Comparison of outcomes after thoracic endovascular aortic repair between current and previous studies.
Authors Perioperative
mortality (%)
Survival Morbidity (%) Complications (%) Length of
stay (d)
Respiratory
failure
Acute renal
failure
Stroke Paralysis Wound Reintervention
Conrad et al2 9.1 58% at 5 y d d d d d d 11.5
Kato et al17 5.3 92% at 1 y 5.3 d 2.6 2.8 2.6 13.2 d
Hanna et al28 0 84% and 84% at 5 y and 7 y, respectively 8.0 4.0 2.0 2.0 d 26.0 5
Xu et al14 1.2 84% at 5 y d 4.5 d d d 4.8 10
Andersen et al13 4.0 86% and 65% at 1 y and 5 y, respectively 2.7 4.0 0 0 d 24.0 4
Current study 2.6 92%, 86%, 82%, and 79% at 1 y, 2 y,
3 y, and 4 y, respectively
6.8 5.1 1.7 0.9 0 4.2 20
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